| Fondaparinux | Enoxaparin | P value |
---|---|---|---|
n = 204 | n = 204 | ||
Gender, male/female | 30/174 | 26/178 | 0.565 |
Age, years | Â | Â | Â |
  Mean ± SD | 73.6 ± 7.6 | 73.2 ± 7.7 | 0.734 |
  Range | 34-87 | 45-89 |  |
Body mass index, kg/m2 | Â | Â | Â |
  Mean ± SD | 25.4 ± 4.0 | 25.5 ± 4.0 | 0.729 |
History of venous thrombosis, n (%) | 3 (1.5%) | 2 (1.0%) | 0.500 |
Comorbidities, n (%) | Â | Â | Â |
  Hypertension | 113 (55.4%) | 98 (48.0%) | 0.137 |
  Ischemic heart disease | 9 (4.4%) | 11 (5.4%) | 0.647 |
  Diabetes | 29 (14.2%) | 27 (13.2%) | 0.774 |
  Cerebrovascular disease | 11 (5.4%) | 7 (3.4%) | 0.335 |
Operation time, minutes | Â | Â | Â |
  Mean ± SD | 131.4 ± 41.7 | 130.2 ± 46.7 | 0.786 |
Primary diseases, n (%) | Â | Â | Â |
  Rheumatoid arthritis | 41 (20.1%) | 27 (13.2%) | 0.063 |
  Osteoarthritis | 161 (78.9%) | 176 (86.3%) | 0.050 |
  Others | 2 (1.0%) | 1 (0.5%) | 0.500 |
General anesthesia | 175 (85.8%) | 150 (73.5%) | 0.002 |
Use of elastic stocking, n (%) | 195 (95.6%) | 184 (90.2%) | 0.034 |
Use of foot pump, n (%) | 184 (90.2%) | 156 (76.5%) | <0.0001 |
Use of tourniquet, n (%) | 187 (91.7%) | 193 (94.6%) | 0.240 |
Use of cement, n (%) | 198 (97.1%) | 198 (97.1%) | 1.000 |
e-GFR, mL/min per 1.73Â m2 | Â | Â | Â |
  Mean ± SD | 74.7 ± 22.1 | 74.2 ± 19.4 | 0.961 |
  Range | 24.1-158.7 | 30.9-147.5 |  |
Serum albumin, g/dL | Â | Â | Â |
  Mean ± SD | 4.0 ± 0.5 | 4.1 ± 0.4 | 0.041 |
  Range | 2.3-5.0 | 2.8-4.9 |  |
Platelet count, 104/μL |  |  |  |
  Mean ± SD | 24.8 ± 6.9 | 24.9 ± 7.2 | 0.913 |